Brink's Q1: Solid Cash Flow, but AMS/DRS Growth Hits Low End of Range

What happened

Brink's reported Q1 2026 revenue growth of 10% (4.5% organic) with AMS/DRS organic growth of 15%, landing at the low end of the 'mid-to-high teens' guide. Cash from operations surged $89M and free cash flow improved $66M year-over-year, providing a near-term liquidity buffer. The NCR Atleos acquisition remains on track to close by Q1 2027, with no apparent delays. However, the 15% AMS/DRS growth rate is exactly the threshold where the DeepValue thesis would begin to weaken, as it reflects a deceleration from prior quarters. Overall, the quarter validated the base-case operational trajectory but did not deliver the re-acceleration needed to justify a more bullish stance.

Implication

The Q1 print confirms that Brink's core cash logistics business is stable and generating strong cash flows, which supports the base-case valuation of ~$125. However, the 15% AMS/DRS organic growth is exactly the figure that the DeepValue report flagged as a 'decrease if' threshold, meaning the bull case for a re-rating toward $155 depends on growth accelerating above 18% in coming quarters. Free cash flow improvement of $66M is a positive, but the capital allocation priority remains deleveraging through end-2027, limiting buyback support. The deal timeline is intact, reducing pendency risk but not eliminating it. Investors should watch for next quarter's AMS/DRS growth rate; if it slips below 15%, the bear case at $85 becomes more probable.

Thesis delta

The Q1 results keep the existing WAIT thesis intact, with AMS/DRS growth at the low end of the guided range and strong cash flow providing a floor. The key shift is that the bull case now requires AMS/DRS growth to re-accelerate to 18%+ in Q2 or Q3 to avoid heading toward the bear scenario. The deal progress on schedule removes one risk but does not offset the growth deceleration concern.